HC Wainwright Issues Positive Estimate for FENC Earnings
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Analysts at HC Wainwright upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a research note issued to investors on Tuesday, March 11th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.13) per share for the quarter, up from their […]
